Swedish snus is a moist, ground oral tobacco that is heat-treated rather than fermented, and used by parking a portion under the upper lip. It is banned across the European Union except in Sweden, which holds a derogation from its 1994 accession terms. It is legal in Sweden, Norway and the United States.
Almost everything distinctive about snus follows from one production decision made a long time ago: heat the tobacco instead of letting bacteria work on it. That choice is why the chemistry differs from American dip, why the cans live in the fridge, and — indirectly — why the legal position across Europe is such a mess.
What makes it Swedish
The difference is pasteurisation. The US National Cancer Institute and CDC describe it in one sentence: “Swedish snus, a snuff-like product, is made from pasteurized and air-cured tobacco that is not fermented. Pasteurization reduces or eliminates bacteria, including those that convert nitrate to nitrite, a key precursor for TSNAs.” (Smokeless Tobacco and Public Health: A Global Perspective, 2014.)
The EU’s SCENIHR committee described the process as: “Finely ground dry tobacco is mixed with aromatic substances, salts, water, and humidifying agents. The product is pasteurised by heating and kept cool to avoid ageing.” A peer-reviewed account by Swedish Match employees — an industry source, and flagged as one — puts numbers on it: heating “involves temperatures up to 80-100 degrees centigrade during several hours”.
Why it matters chemically: tobacco-specific nitrosamines form during “curing, fermentation and ageing”, in IARC’s words. Kill the bacteria that turn nitrate into nitrite and you interrupt the pathway. NCI and CDC draw the conclusion directly: “Because bacterial activity is very low in snus products, it is not surprising that snus contains much lower levels of nitrite and TSNAs than moist snuff made with fermented fire-cured tobacco that is not pasteurized.”
Measured, that gap looks like this. Stepanov and colleagues found Swedish General snus at 1.66 µg NNN/g and 0.464 µg NNK/g, against traditional US brands averaging 4.41 and 1.20 µg/g — roughly 2.4 times the total TSNA load (Nicotine & Tobacco Research, 2008). The same paper notes some newer US products now measure comparably, so “Swedish snus is always lowest” would overstate it.
And IARC’s caution belongs here too: “even in Swedish snus, levels of TSNA are comparable with those in cigarette smoke”. Lower than fermented dip is not the same as low.
The formats
| Format | What it is | Notes |
|---|---|---|
| Lös (loose) | Unpouched snus, hand-formed into a portion | Packed in paraffin-coated cardboard cans |
| Original portion | Pre-packed sachet, brown pouch | Named as a distinct product type in FDA’s authorised product list |
| White portion | Pre-packed sachet, white pouch | Also named distinctly by FDA; no published technical definition of the difference |
| White dry portion | Drier variant | FDA lists e.g. “Dry Mint Portion Original Mini” |
| Mini / large | Portion size | Manufacturer-set; no standard |
One honest caveat on that table. The three portion types are real and consistently used — FDA’s scientific review of the General Snus applications records products “in ‘original,’ ‘white,’ and ‘dry’ portion types” (FDA). But I could not find a statute, regulator document, peer-reviewed paper or company filing that states what physically distinguishes them. Every source that explains it is a retailer or a blog. So I am telling you the categories exist and leaving the mechanism blank rather than making one up.
Why it is banned in the EU
Article 17 of the Tobacco Products Directive is one sentence: “Member States shall prohibit the placing on the market of tobacco for oral use, without prejudice to Article 151 of the Act of Accession of Austria, Finland and Sweden.”
Article 2(8) defines what that catches: “all tobacco products for oral use, except those intended to be inhaled or chewed, made wholly or partly of tobacco, in powder or in particulate form or in any combination of those forms, particularly those presented in sachet portions or porous sachets”.
The words “or chewed” are doing a lot of work. That carve-out is why chewing tobacco and chew bags remain saleable in the EU while snus does not.
Sweden’s exemption is not something the Directive granted. It comes from the 1994 Act of Accession, whose Annex XV provides that the oral tobacco prohibition “shall not apply in Sweden and Norway, with the exception of the prohibition to place this product on the market in a form resembling a food product”. Article 17 simply preserves it. Recital 20 spells out the consequence: regulating snus ingredients “should, in accordance with the principle of subsidiarity, remain with Sweden, where the sale of this product is permitted”.
Two points people get wrong. The derogation is territorial — it permits sale within Sweden and is not an export right, which is why ordering snus into another member state is a different legal question from buying it in Stockholm. And although the 1994 text names Norway, Norway rejected membership by referendum; its position today rests on its own law, not on that instrument.
The ban has been tested and held. In Case C-151/17 Swedish Match AB v Secretary of State for Health, decided 22 November 2018, the Court of Justice concluded that consideration of the question referred “has disclosed nothing capable of affecting the validity of Article 1(c) and Article 17” of the Directive (judgment).
How Sweden and Norway actually regulate it
In Sweden, snus is handled under food law rather than by the tobacco regulator. The Food Act, Livsmedelslagen (2006:804), equates snus with food for regulatory purposes — “Med livsmedel jämställs i lagen…2. snus, snusliknande produkter och tuggtobak” — even though the Food Agency’s own guidance is explicit that “Snus, snusliknande produkter och tuggtobak är inte livsmedel enligt definitionen av livsmedel”: snus is not food, it is regulated as if it were. The operative rule is LIVSFS 2024:2, which replaced the 2012 regulation.
Sweden’s minimum age is 18, under Lag (2018:2088) om tobak och liknande produkter: “Tobaksvaror, elektroniska cigaretter och påfyllningsbehållare får inte säljas eller på annat sätt lämnas ut i näringsverksamhet till den som inte har fyllt 18 år.”
Norway regulates snus as a tobacco product under its own tobacco legislation. Sale to under-18s is prohibited — “Salg av tobakksvarer, tobakkssurrogater, tobakksutstyr og tobakksimitasjoner til personer under 18 år er forbudt” (Helsedirektoratet) — and standardised plain packaging applies: “Påbudet om standardisert innpakning gjelder kun for sigaretter, rulletobakk og snus”. This is why Norwegian cans are visually identical apart from the brand name in a standard typeface.
Country-by-country detail is in the global map and the regulation tracker.
What the health authorities actually conclude
This is the section where I am going to quote and attribute rather than characterise, because the temptation to round these findings up or down is strong in both directions.
IARC classifies smokeless tobacco as carcinogenic to humans: tobacco smoking, second-hand smoke and smokeless tobacco “were all reaffirmed as carcinogenic to humans (Group 1)” (IARC press release on Monographs Vol. 100E). The named sites are oral cavity, pancreas and oesophagus.
SCENIHR, the EU scientific committee, concluded in 2008 that “STP are addictive and their use is hazardous to health”, that “evidence on the effectiveness of STP as a smoking cessation aid is insufficient”, and — specifically on snus — that a high risk of oral cancer “has been shown for various STP but has not been proven for Swedish moist snuff (snus)”. That last clause is an absence of proof, not a finding of safety, and it is frequently quoted as though it were the latter.
FDA went further than either, but only in one narrow direction. On 22 October 2019, renewed on 7 November 2024 for eight General Snus products, it authorised exactly this claim and no other: “Using General Snus instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis.” FDA’s underlying review found “the levels of NNN and NNK, two potent carcinogens in smokeless tobacco products, in these General Snus products are lower than those in the vast majority of smokeless tobacco products on the U.S. market”.
Read that claim exactly as written. It is comparative and substitutional — instead of cigarettes. It is not a claim about snus against using nothing. It is a closed list of six named conditions; FDA authorised nothing about pancreatic or oesophageal cancer, gum disease, tooth loss or addiction. And FDA pairs it with: “There is no safe tobacco product, and those who do not use tobacco products should not start.” The order also does not permit marketing that could mislead consumers “into believing that the products are endorsed or approved by FDA, or that FDA deems the products to be safe for use by consumers”.
Sweden’s numbers, and what they do and do not show
Sweden has the lowest daily smoking rate in the EU. Eurostat, from the 2019 European Health Interview Survey: “Among the EU Member States, the share of daily smokers ranged from 6.4 % in Sweden and 9.9 % in Finland to 23.6 % in Greece and 28.7 % in Bulgaria”. Sweden’s own Public Health Agency reports that in 2024, 5% of those aged 16–84 smoked daily.
Snus use is far higher than smoking. Folkhälsomyndigheten reports that in 2024, “22 procent av männen och 10 procent av kvinnorna i åldern 16–84 år” used snus daily. Among women aged 16–29, daily use rose from 3% in 2018 to 18% in 2024.
I am giving you both sets of figures because they are both true and both relevant. I am not going to put them next to each other and let the layout make an argument. These are independent measurements from different surveys; neither establishes that one caused the other, and SCENIHR’s finding that cessation evidence is “insufficient” sits directly against the causal reading. The six-fold rise in daily snus use among young Swedish women over six years is not a harm-reduction success story on any reading, and an honest page does not leave it out.
Storage: why the cans are in the fridge
Snus is refrigerated, and shops that sell it properly keep it chilled. The reason is less dramatic than it is usually made out to be.
The clearest statement on the record comes from the Swedish Match-authored paper: “Snus ageing can be slowed by keeping the product refrigerated below 8 degrees centigrade. Ageing is more or less halted if the product is deep frozen”, and “retailers are encouraged to keep the snus refrigerated in order to meet the criteria for the ‘best-before’ labeling”. The company’s production description attributes cold storage to maturation and flavour.
The same paper also states that “nitrosamines are not formed in the container during storage, even if kept at room temperature”. You will often read that refrigeration keeps TSNAs down; I went looking for a source for that and could not find one. The only source that addresses it directly says the opposite — and it is industry-authored, with an obvious interest in saying so, so I would treat the point as contested rather than settled. What is not contested is that warm snus dries out, ages and tastes worse.
Frequently asked questions
Is snus the same as a nicotine pouch? No. Snus contains tobacco; a nicotine pouch does not. That single difference decides how each is regulated almost everywhere. See the nicotine pouch guide.
Can I legally buy snus in the EU outside Sweden? It cannot lawfully be placed on the market in other member states. Buying it in Sweden and bringing it home is a separate question turning on your own country’s rules, and it is not one I can answer generically.
Is snus safer than smoking? The only regulator to have authorised a comparative claim is FDA, and its claim is limited to six named conditions and conditional on substituting for cigarettes. Every authority quoted above also says no tobacco product is safe.
Does snus help you quit smoking? SCENIHR’s conclusion is that the evidence is insufficient. No regulator has authorised a cessation claim for it, and it is not approved as a cessation treatment anywhere I am aware of.
How long does a can last unopened? Manufacturers date them for a best-before window that assumes refrigeration. Frozen, ageing largely stops; at room temperature it accelerates.
Sources
- Directive 2014/40/EU, Articles 2(8) and 17, recital 20; 1994 Act of Accession, Annex XV; Case C-151/17
- NCI/CDC, Smokeless Tobacco and Public Health: A Global Perspective (2014)
- SCENIHR, Health Effects of Smokeless Tobacco Products (2008)
- IARC press release, Monographs Vol. 100E; IARC Monographs Vol. 89
- Stepanov et al., Nicotine & Tobacco Research 2008;10(12):1773–82
- FDA, General Snus MRTP applications; FDA renewal, 7 November 2024; FDA scientific review
- Livsmedelslagen (2006:804); LIVSFS 2024:2; Lag (2018:2088)
- Helsedirektoratet, salg av tobakksvarer; standardised packaging
- Eurostat, Tobacco consumption statistics; Folkhälsomyndigheten, tobaksrökning; snusning i Sverige
- Rutqvist LE et al., “Swedish snus and the GothiaTek® standard”, Harm Reduction Journal 2011;8:11. All authors are or have been Swedish Match employees.
- Swedish Match, snus production (commercial source)